WHO Criteria (depending on T- scores)
T score |
Diagnosis |
Between 1 to -1 |
Normal |
Between -1.0 to -2.5 |
Osteopenia |
<-2.5 |
Osteoporosis |
<-2.5 plus one or more fragility fractures |
Severe Osteoporosis |
Condition |
To start treatment or not |
Men and Women with Osteoporosis with fracture (T score<-2.5) |
Yes |
Men and Women with Osteoporosis without fracture (T score<-2.5) |
Yes, if secondary risk for fracture present and age >60 in men and>55 in Women |
Men and Women with Osteoporosis without fracture (T score<-2.5) |
No, if only modifiable factors present in age<60 in men and <55 in women |
Women and men with secondary Osteoporosis (T score<-2.5) |
Yes |
Men and Women with Osteopenia with fracture (T score -1.0 to -2.5) |
Recommended for people with vertebral fracture Generally recommended for people with on-vertebral fracture |
Men and Women with Osteopenia without fracture (T score -1.0 to -2.5) |
Limited Data Consider treatment for men and women aged over 65 if T-score is very low (-2.0 to -2.5) and if other risk factors are present. Monitor and maintain adequate calcium intake and vitamin D levels and recommend a regular exercise program. Educate regarding the signs of a spinal fracture. Repeat DXA scan in 2-5 years.
|
Special circumstances
|
All people on corticosteroid therapy (oral or inhaled) of 7.5 mg per day for at least 3 months with a T-Score of -1.5 or less should receive drug therapy Women with breast cancer starting treatment with aromatase inhibitors should be assessed for their absolute fracture risk and may benefit from treatment with anti-resorptive agents. |
People with Normal BMD |
No need But if risk factors then monitor calcium and Vit D Repeat DEXA in 2-5 years |